Skip to main content
Clinical Trials/CTRI/2021/09/036975
CTRI/2021/09/036975
Not yet recruiting
未知

Evaluation of ophthalmic manifestations andcorrelation with serum level of Vascular endothelial growth factor-D in COVID-19 recovered subjects

ARCHANA T R0 sites0 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
ARCHANA T R
Status
Not yet recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Observational

Investigators

Sponsor
ARCHANA T R

Eligibility Criteria

Inclusion Criteria

  • who have recovered from SARS\-CoV\-2 diseases

Exclusion Criteria

  • Subjects who had undergone any ocular or cranial surgery other than uneventful cataract surgery
  • Subjects having pre\-existing ocular pathology like retinal diseases, uveitis, media opacities and glaucoma; or central nervous system disease like tumors, demyelination, degeneration, etc.

Outcomes

Primary Outcomes

Not specified

Similar Trials